Pyxis Oncology, Inc. · NASDAQ:PYXS
Pyxis Oncology, Inc. shareholders
As of Jun 30, 2026, 74 institutions reported holding Pyxis Oncology, Inc., 40.9% of its shares. Largest: GordonMD Global Investments LP, Pfizer Inc and Laurion Capital Management LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Pyxis Oncology, Inc. | Change | Filed |
|---|---|---|---|---|
| GordonMD Global Investments LP | 10M | 12.0% | +5.9M | Aug 14, 2026 |
| Pfizer Inc | 7.03M | 8.4% | no change | Aug 13, 2026 |
| Laurion Capital Management LP | 4.9M | 5.9% | −96,445 | Aug 13, 2026 |
| Vanguard | 2.4M | 2.9% | +44,576 | Aug 13, 2026 |
| Atle Fund Management AB | 966K | 1.2% | +769K | Jul 24, 2026 |
| BlackRock | 868K | 1.0% | +79,095 | Aug 7, 2026 |
| Palo Alto Investors LP | 864K | 1.0% | −146K | Aug 19, 2026 |
| Marshall Wace, LLP | 831K | 1.00% | +476K | Aug 13, 2026 |
| Renaissance Technologies | 772K | 0.93% | −116K | Aug 13, 2026 |
| Geode Capital | 592K | 0.71% | −6,272 | Aug 12, 2026 |